Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Boehm

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BMC Pulmonary Medicine|March 4, 2018
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertensionMario Boehm, Nadine Arnold, Adam Braithwaite, et al.
Circulation|August 15, 2020
A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular LesionsLea C Steffes, Alexis A Froistad, Adam Andruska, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2017
ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial HypertensionGrant R Budas, Mario Boehm, Baktybek Kojonazarov, et al.
Biomed Research International|February 11, 2015
5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failureWiebke Janssen, Yves Schymura, Tatyana Novoyatleva, et al.
American Journal of Respiratory Cell and Molecular Biology|June 29, 2017
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular HypertrophyBaktybek Kojonazarov, Tatyana Novoyatleva, Mario Boehm, et al.
American Journal of Respiratory Cell and Molecular Biology|May 3, 2021
Improving Right Ventricular Function by Increasing BMP Signaling with FK506Mario Boehm, Xuefei Tian, Md Khadem Ali, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2018
FHIT, a Novel Modifier Gene in Pulmonary Arterial HypertensionSvenja Dannewitz Prosseda, Xuefei Tian, Kazuya Kuramoto, et al.
Nature Communications|May 8, 2026
Persistence of alveolar fibroblast-derived ADAMTS4+ cells in a preclinical model of delayed pulmonary fibrosis resolutionMahsa Zabihi, Ali Khadim, Arun Lingampally, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Circulation Research|May 21, 2024
3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary HypertensionKenzo Ichimura, Mario Boehm, Adam M Andruska, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Pulmonary Medicine|March 4, 2018
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertensionMario Boehm, Nadine Arnold, Adam Braithwaite, et al.
Circulation|August 15, 2020
A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular LesionsLea C Steffes, Alexis A Froistad, Adam Andruska, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2017
ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial HypertensionGrant R Budas, Mario Boehm, Baktybek Kojonazarov, et al.
Biomed Research International|February 11, 2015
5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failureWiebke Janssen, Yves Schymura, Tatyana Novoyatleva, et al.
American Journal of Respiratory Cell and Molecular Biology|June 29, 2017
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular HypertrophyBaktybek Kojonazarov, Tatyana Novoyatleva, Mario Boehm, et al.
American Journal of Respiratory Cell and Molecular Biology|May 3, 2021
Improving Right Ventricular Function by Increasing BMP Signaling with FK506Mario Boehm, Xuefei Tian, Md Khadem Ali, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2018
FHIT, a Novel Modifier Gene in Pulmonary Arterial HypertensionSvenja Dannewitz Prosseda, Xuefei Tian, Kazuya Kuramoto, et al.
Nature Communications|May 8, 2026
Persistence of alveolar fibroblast-derived ADAMTS4+ cells in a preclinical model of delayed pulmonary fibrosis resolutionMahsa Zabihi, Ali Khadim, Arun Lingampally, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Circulation Research|May 21, 2024
3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary HypertensionKenzo Ichimura, Mario Boehm, Adam M Andruska, et al.
Pageof 3